1. Home
  2. GCBC vs FHTX Comparison

GCBC vs FHTX Comparison

Compare GCBC & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greene County Bancorp Inc.

GCBC

Greene County Bancorp Inc.

N/A

Current Price

$23.70

Market Cap

374.8M

Sector

Finance

ML Signal

N/A

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$4.87

Market Cap

332.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCBC
FHTX
Founded
1889
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
374.8M
332.2M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
GCBC
FHTX
Price
$23.70
$4.87
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$11.50
AVG Volume (30 Days)
10.5K
131.3K
Earning Date
04-20-2026
05-13-2026
Dividend Yield
1.70%
N/A
EPS Growth
26.21
25.32
EPS
1.13
N/A
Revenue
$4,117,000.00
$30,909,000.00
Revenue This Year
N/A
$7.81
Revenue Next Year
N/A
$17.72
P/E Ratio
$20.78
N/A
Revenue Growth
11.06
36.75
52 Week Low
$20.62
$3.27
52 Week High
$26.04
$6.95

Technical Indicators

Market Signals
Indicator
GCBC
FHTX
Relative Strength Index (RSI) 60.26 46.82
Support Level $22.79 $4.42
Resistance Level $25.09 $5.85
Average True Range (ATR) 0.59 0.28
MACD 0.12 0.03
Stochastic Oscillator 75.22 58.82

Price Performance

Historical Comparison
GCBC
FHTX

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: